Apyx Medical Corp — Director's Dealing 2021

Mar 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2021-03-08

Reporting Person: Waldman Lawrence (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Common Stock	M	5563	$2.81	Acquired	5563	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-08	Stock Option (Option to Buy)	$2.81	X	7500	Disposed	2021-03-18	Common Stock (7500.0)	Direct

Footnotes

F1: The transactions reported reflect the net exercise of stock options.